XML 21 R8.htm IDEA: XBRL DOCUMENT v3.19.2
Note 2 - Summary of Significant Accounting Policies
12 Months Ended
Jun. 30, 2019
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
Note
2.
Summary of Significant Accounting Policies
 
Principles of Consolidation.
The accompanying consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany transactions and accounts have been eliminated in consolidation.
 
Reclassifications
.
Certain prior year amounts have been reclassified to conform to the current year presentation.
 
Use of Estimates.
The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Management bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are
not
readily apparent from other sources. The most significant estimates include:
 
●     sales returns and allowances;
●     trade marketing and merchandising;
●     allowance for doubtful accounts;
●     inventory valuation;
●     valuation and recoverability of long-lived and intangible assets;
●     income taxes and valuation allowance on deferred income taxes, and;
●     accruals for, and the probability of, the outcome of any current litigation.
 
On a continual basis, management reviews its estimates utilizing currently available information, changes in facts and circumstances, historical experience and reasonable assumptions. After such reviews, and if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates.
 
Derivative Liabilities
.
The Company generally does
not
use derivative financial instruments to hedge exposures to cash flow or market risks. However, certain other financial instruments, such as warrants and embedded conversion features on the subordinated convertible debt, are classified as derivative liabilities due to protection provisions within the agreements. Such financial instruments are initially recorded at fair value using the Black Scholes model and subsequently adjusted to fair value at the close of each reporting period. The Company accounts for derivative instruments and debt instruments in accordance with the interpretative guidance of ASC
815
and associated pronouncements related to the classification and measurement of warrants and instruments with conversion features.
 
Revenue Recognition.
The Company recognizes product sales revenue, the prices of which are fixed and determinable, when title and risk of loss have transferred to the customer, when estimated provisions for product returns, rebates, charge-backs and other sales allowances are reasonably determinable, and when collectability is reasonably assured. Accruals for these items are presented in the consolidated financial statements as reductions to sales. The Company’s net sales represent gross sales invoiced to customers, less certain related charges for discounts, returns, rebates, charge-backs and other allowances. Cost of sales includes the cost of raw materials and all labor and overhead associated with the manufacturing and packaging of the products. Gross margins are affected by, among other things, changes in the relative sales mix among our products and valuation and/or charge off of slow moving, expired or obsolete inventories.  To perform revenue recognition for arrangements within the scope of ASC
606,
the Company performs the following
five
steps:
 
 
identification of the promised goods or services in the contract;
 
determination of whether the promised goods or serves are performance obligations including whether they are distinct in the context of the contract;
 
measurement of the transaction price, including the constraint on variable consideration;
 
allocation of the transaction price to the performance obligations based on estimated selling prices; and
 
recognition of revenue when (or as) the Company satisfies each performance obligation.  A performance obligation is a promise to transfer a distinct good or service to the customer and is the unit of account in ASC
606.
 
 
Shipping and Handling Costs.
Shipping and handling costs were approximately
$205
 and
$207
for the fiscal years ended
June 30, 2019
and
2018,
respectively, and are included in cost of sales in the accompanying Consolidated Statements of Operations.
 
Trade Marketing and Merchandising.
In order to support the Company’s proprietary nutraceutical product lines, various promotional activities are conducted through the retail trade, distributors or directly with consumers, including in-store display and product placement programs, feature price discounts, coupons, and other similar activities. The Company regularly reviews and revises, when it deems necessary, estimates of costs to the Company for these promotional programs based on estimates of what will be redeemed by the retail trade, distributors, or consumers. These estimates are made using various techniques, including historical data on performance of similar promotional programs. Differences between estimated expense and actual performance are generally
not
material and are recognized as a change in management’s estimate in a subsequent period.
 
Advertising.
Advertising costs are expensed as incurred. Advertising expense was approximately
$6
and
$17
for the fiscal years ended
June 30, 2019
and
2018,
respectively.
 
Stock-Based Compensation.
The Company has
two
stock-based compensation plans that have outstanding options issued in accordance with such plans. The Company periodically grants stock options to employees and directors in accordance with the provisions of its stock option plans, with the exercise price of the stock options being set at the closing market price of the common stock on the date of grant. Stock based compensation expense is recognized based on the estimated fair value, utilizing a Black-Scholes option pricing model, of the instrument on the date of grant over the requisite vesting period, which is generally
three
years.
 
Income Taxes
. The Company accounts for income taxes using the asset and liability method. Accordingly, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in the tax rate is recognized in income or expense in the period that the change is effective. Tax benefits are recognized when it is probable that the deduction will be sustained. A valuation allowance is established when it is more likely than
not
that all or a portion of a deferred tax asset will
not
be realized.
 
The Company files a U.S. federal income tax return as well as returns for various states.  The Company’s income taxes have
not
been examined by any tax authorities for the periods subject to review by such taxing authorities, except for the State of New Jersey tax filings for MDC which were reviewed by the State of New Jersey for the then open tax periods of
2014
through
2017
and resulted in an adjustment of approximately
$23
for all periods reviewed and included in the income tax provision in the fiscal year ended
June 30, 2019.
Uncertain tax positions, if any, taken on our tax returns are accounted for as liabilities for unrecognized tax benefits. The Company recognizes interest and penalties, if any, related to unrecognized tax benefits in general and administrative expenses in the Consolidated Statements of Operations. There were
no
liabilities recorded for uncertain tax positions at
June 30, 2019
or
2018.
 
Earnings Per Share.
Basic earnings per common share amounts are based on weighted average number of common shares outstanding. Diluted earnings per share amounts are based on the weighted average number of common shares outstanding, plus the incremental shares that would have been outstanding upon the assumed exercise of all potentially dilutive stock options, warrants and convertible debt, subject to anti-dilution limitations using the treasury stock method and if converted method.
 
Fair Value of Financial Instruments.
Generally accepted accounting principles require disclosing the fair value of financial instruments to the extent practicable for financial instruments which are recognized or unrecognized in the balance sheet. The fair value of the financial instruments disclosed herein is
not
necessarily representative of the amount that could be realized or settled, nor does the fair value amount consider the tax consequences of realization or settlement.
 
In assessing the fair value of financial instruments, the Company uses a variety of methods and assumptions, which are based on estimates of market conditions and risks existing at the time. For certain instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, it was estimated that the carrying amount approximated fair value because of the short maturities of these instruments. All debt is based on current rates at which the Company could borrow funds with similar remaining maturities and approximates fair value.
 
Accounts Receivable and Allowance for Doubtful Accounts.
In the normal course of business, the Company extends credit to customers. Accounts receivable, less the allowance for doubtful accounts, reflect the net realizable value of receivables, and approximate fair value. The Company believes there is
no
concentration of credit risk with any single customer whose failure or nonperformance would materially affect the Company’s results other than as discussed in Note
9
(c) – Significant Risks and Uncertainties – Major Customers. On a regular basis, the Company evaluates its accounts receivables and establishes an allowance for doubtful accounts based on a combination of specific customer circumstances, credit conditions, and historical write-offs and collections. The allowance for doubtful accounts as of
June 30, 2019
and
2018
was
$84
and
$134,
respectively. Accounts receivable are charged off against the allowance after management determines that the potential for recovery is remote.
 
Inventories.
Inventories are stated at the lower of cost or net realizable value. Cost is determined using the
first
-in,
first
-out method. Allowances for obsolete and overstock inventories are estimated based on “expiration dating” of inventory and projection of sales.
 
Property and Equipment.
Property and equipment are recorded at cost and are depreciated using the straight line method over the following estimated useful lives:
 
Building
15
Years
Leasehold Improvements   Shorter of estimated useful life or term of lease
Machinery and Equipment 
7
Years
Transportation Equipment
5
Years
       
 
Impairment of Long-Lived Assets.
Long-lived assets are reviewed for impairment when circumstances indicate that the carrying value of an asset
may
not
be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of the assets to the future net cash flows estimated by the Company to be generated by such assets. If such assets are considered to be impaired, the impairment to be recognized is the amount by which the carrying amount of the assets exceeds the fair value of the assets. Assets to be disposed of by sale are recorded as held for sale at the lower of carrying value or estimated net realizable value. Tests for impairment or recoverability are performed at least annually and require significant management judgment and the use of estimates which the Company believes are reasonable and appropriate at the time of the impairment test. Future unanticipated events affecting cash flows and changes in market conditions could affect such estimates and result in the need for an impairment charge. The Company also re-evaluates the periods of amortization to determine whether circumstances warrant revised estimates of current useful lives.
No
impairment losses were identified or recorded in the fiscal years ended
June 30, 2019
and
2018
on the Company’s other intangible assets.
 
Investment in iBio, Inc.  
Prior to the adoption of ASU
2016
-
01
on
July 1, 2018,
the Company accounted for its investment in iBio, Inc. (“iBio”) common stock on the cost basis as it retained approximately
6%
of its interest in iBio (the “iBio Stock”) at the time of the spin-off of this subsidiary in
August 2008.  
The Company reviewed its investment in iBio for impairment and recorded a loss when there was deemed to be a permanent impairment of the investment.  To date, there were cumulative impairment charges of approximately
$2,562
and as of
June 30, 2019,
an unrealized loss of approximately
$23.
  The market value of the iBio Stock as of
June 30, 2019
and
2018,
was approximately
$84
 and
$107,
respectively, based on the trade price at the close of trading on
June 30, 2019
and
2018,
respectively.  The investment in iBio is included in other current assets in the consolidated balance sheets as of
June 30, 2019
and
2018
at the respective market values.
 
Investment in AgroSport LLC.  
The Company accounts for its investment in AgroSport LLC (“AGS”) on the equity method. On
June 1, 2018,
AgroLabs contributed the AgroSport product line to AGS in exchange for a
one
third
interest in AGS. The contribution included the website, www.agrosport.com, all trademarks and all other intangible assets associated with the AgroSport product line and a future capital contribution commitment of
$10.
The equity basis value of AgroSport was
$0
and
$89,
as of
June 30, 2019
and
2018,
respectively and is included in other current assets.
 
Accounting Pronouncements
Recently Adopted
 
In
May 2014,
the FASB issued ASU
2014
-
09,
“Revenue from Contracts with Customers”, Topic
606.
  This update affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets, unless those contracts are within the scope of other standards. The guidance in this update supersedes the revenue recognition requirements in Topic
605,
Revenue Recognition and most industry-specific guidance. The core principle of the guidance is that an entity should recognize revenue to illustrate the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The new guidance also includes a cohesive set of disclosure requirements that will provide users of financial statements with comprehensive information about the nature, amount, timing, and uncertainty of revenue and cash flows arising from a reporting organization’s contracts with customers.
 
During
2016,
the FASB issued several accounting updates (ASU
No.
2016
-
08,
2016
-
10
and
2016
-
12
) to clarify implementation guidance and correct unintended application of the guidance. The standard allows for either “full retrospective” adoption, meaning the standard is applied to all of the periods presented, or “modified retrospective” adoption, meaning the standard is applied only to the most current period presented in the financial statements.  This new guidance was effective for the Company beginning on
July 1, 2018,
and Note
13
 provides the related disaggregated revenue disclosures.  The adoption of this standard using the modified retrospective approach did
not
have a material impact on the Company’s revenue recognition accounting policy or its Consolidated Financial Statements. 
 
 
In
January 2016,
the FASB issued ASU
No.
2016
-
01,
Financial Instruments – Overall, (Subtopic
825
-
10
) “Recognition and Measurement of Financial Assets and Financial Liabilities”, which addresses certain aspects of recognition, measurement, presentation and disclosure of financial instruments.  Under this guidance, companies have to measure equity investments, except those accounted for under the equity method, at fair value and recognize changes in fair value in net income. The adoption of this standard on
July 1, 2018,
by Company did
not
have a material effect on its Consolidated Financial Statements.
 
In
February 2016,
the FASB issued ASU
No.
2016
-
02,
Leases (Topic
842
), a new standard related to leases to increase transparency and comparability among organizations by requiring the recognition of right-of-use (“ROU”) assets and lease liabilities on the balance sheet. Most prominent among the changes in the standard is the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases under current U.S. GAAP. Under the standard, disclosures are required to meet the objective of enabling users of financial statements to assess the amount, timing, and uncertainty of cash flows arising from leases. We will be required to recognize and measure leases existing at, or entered into after, the beginning of the earliest comparative period presented using a modified retrospective approach, with certain practical expedients available.
 
We elected to early adopt the standard effective
July 1, 2018. 
We elected the available practical expedients on adoption. In preparation for adoption of the standard, we have implemented internal controls and key system functionality to enable the preparation of financial information. The standard had a material impact on our consolidated balance sheets, but did
not
have a material impact on our consolidated income statements. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases, while our accounting for capital leases remained substantially unchanged.
 
Adoption of this standard resulted in the recognition of additional ROU assets and lease liabilities for operating leases and had the following impact to the reported results as of
July 1, 2018
on our consolidated financial statements:
 
Consolidated Statement of Financial Condition
 
As Reported
   
New Lease Standard Adjustment
   
As Adjusted
 
                         
Operating lease right-of-use assets
  $
-
    $
69
    $
69
 
Operating lease right-of-use assets - Vitamin Realty, LLC
   
-
     
3,668
     
3,668
 
Operating lease liabilities
   
-
     
69
     
69
 
Operating lease liabilities - Vitamin Realty, LLC
   
-
     
3,677
     
3,677
 
Current portion of long term debt, net
   
773
     
-
     
773
 
Long term debt, net
   
3,624
     
-
     
3,624
 
Current portion - Subordinated convertible note, net - CD Financial, LLC
   
 5,269
     
 -
     
 5,269
 
 
In
August, 2016,
the FASB issued ASU
No.
2016
-
15,
“Statement of Cash Flows (Topic
230
): Classification of Certain Cash Receipts and Cash Payments,” which clarifies how certain cash receipts and payments are to be presented in the statement of cash flows. The guidance was effective for the Company on
July 1, 2018
and did
not
have a material impact on the Company’s Consolidated Financial Statements.
 
Accounting Pronouncements
Not
Yet Adopted
 
In
October, 2016,
the FASB issued ASU
No.
2016
-
16,
“Income Taxes (Topic
740
): Intra-Entity Transfers of Assets Other than Inventory,” which eliminates the requirement to defer recognition of income taxes on intra-entity transfers until the asset is sold to an outside party. The new guidance requires the recognition of current and deferred income taxes on intra-entity transfers of assets other than inventory, such as intellectual property and property, plant and equipment, when the transfer occurs. The guidance is effective for the Company on
July 1, 2019
and early adoption is permitted. The standard requires a “modified retrospective” adoption, meaning the standard is applied through a cumulative adjustment in retained earnings as of the beginning of the period of adoption. This new guidance did
not
have a material impact on the Company’s Consolidated Financial Statements.
 
In
July 2017,
the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2017
-
11,
"Earnings Per Share (Topic
260
) Distinguishing Liabilities from Equity (Topic
480
) Derivatives and Hedging (Topic
815
)," which addresses the complexity of accounting for certain financial instruments with down round features.  The amendments are effective for the Company on
July 1, 2019
for the fiscal year ended
June 30, 2020,
and the interim periods within it.  Early adoption was available.  The Company is
not
expecting a material impact on the Company’s Consolidated Financial Statements.
 
On
August 28, 2018,
the Financial Accounting Standards Board (“FASB”) issued ASU
2018
-
13,
 Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement (Topic
820
), which changes the fair value measurement disclosure requirements of ASC
820.
This ASU removes certain disclosure requirements regarding the amounts and reasons for transfers between Level
1
and Level
2
of the fair value hierarchy and the policy for timing of transfers between the levels. This ASU also adds disclosure requirements regarding unrealized gains and losses included in Other Comprehensive Income for recurring Level
3
fair value measurements and the range and weighted average of unobservable inputs used in Level
3
fair value measurements. ASU
2018
-
13
 is effective for all entities with fiscal years beginning after
December 15, 2019,
including interim periods therein. Early adoption is permitted for any eliminated or modified disclosures upon issuance of ASU
2018
-
13.
The Company is currently evaluating the impact of adopting this standard.
 
In
June 2016,
the FASB issued ASU
2016
-
13
 “Financial Instruments-Credit Losses-Measurement of Credit Losses on Financial Instruments”. This guidance replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance applies to loans, accounts receivable, trade receivables and other financial assets measured at amortized cost, loan commitments, debt securities and beneficial interests in securitized financial assets, but the effect on the Company is projected to be limited to accounts receivable. The guidance will be effective for the fiscal year beginning on
January 
1,
2020,
including interim periods within that year. The Company is currently evaluating the impact of adopting this standard.
 
In
May 2019,
the FASB issued ASU
2019
-
05
“Financial Instruments-Credit Losses (Topic
326
)” which provides transition relief for companies adopting ASU
2016
-
13.
This guidance amends ASU
2016
-
13
to allow companies to elect, upon adoption of ASU
2016
-
13,
the fair value option on financial instruments that were previously recorded at amortized cost under certain circumstances. Companies are required to make this election on and instrument by instrument basis. The guidance will be effective for the fiscal year beginning after
December 15, 2019,
including interim periods within that year. The Company is currently evaluating the impact of adopting this standard.